Results 151 to 160 of about 16,023 (215)

Loop Quantum Photonic Chip for Coherent Multi‐Time‐Step Evolution

open access: yesLaser &Photonics Reviews, EarlyView.
A loop quantum photonic chip (Loop‐QPC) enabling efficient multi‐step quantum simulation in a single run is demonstrated. Combining recirculating loops with cycle‐or‐measure control, Loop‐QPC eliminates repeated reprogramming and reduces loss. Experimental demonstration of three‐step unitary evolution confirms high‐fidelity operation, showcasing the ...
Yuancheng Zhan   +9 more
wiley   +1 more source

Countering Social Information: Low Identity Integration Leads to Nonconformity in Consumption Choices

open access: yesPsychology &Marketing, EarlyView.
ABSTRACT We examine how the processing of social information for identity‐driven consumption choices is moderated by individual differences in the psychological management of multiple identities. We specifically show that consumers who experience their multiple identities as more incompatible—or low identity integrators—are less likely to conform to ...
Kathrin J. Hanek, Stephen M. Garcia
wiley   +1 more source

The Role of Perfumes in Surgical Wound Infections and Wound Healing: A Case-Control Study. [PDF]

open access: yesInt Wound J
Fathuldeen AA   +5 more
europepmc   +1 more source

Myasthenia Gravis and Thymoma

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Benjamin Claytor   +5 more
wiley   +1 more source

Prevalence, Antimicrobial Resistance, and Molecular Characteristics of MRSA in Saudi Arabia: A Retrospective Study. [PDF]

open access: yesMicroorganisms
Moursi SA   +9 more
europepmc   +1 more source

The Uncharted Territory of the New Obesity Drugs in Users Without Obesity: A Sociomedical Perspective

open access: yesObesity, EarlyView.
ABSTRACT The off‐label use of glucagon‐like peptide‐1 receptor agonists (GLP‐1ra) among people without obesity and/or diabetes is rapidly expanding, despite a lack of clinical justification or safety data in this population. This Perspective explores the sociomedical dimensions of this trend, highlighting key research gaps and emerging hypotheses ...
Fernanda Baeza Scagliusi   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy